Is Dingdang Health Technology Group (HKG:9886) In A Good Position To Invest In Growth?
Feb 17
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedFeb 21, 2025
DataAggregated Company Financials
Companies5
- 7D16.6%
- 3M27.8%
- 1Y20.8%
- YTDn/a
In the last week, the Drug Retail industry is up 25%, with all of the companies up. In the last 12 months, the industry was up 27%. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 22 Feb 2025 | HK$229.7b | HK$104.1b | HK$3.6b | 55.9x | 63.8x | 2.2x |
| Mon, 20 Jan 2025 | HK$154.8b | HK$103.3b | HK$3.6b | 37x | 43.3x | 1.5x |
| Wed, 18 Dec 2024 | HK$157.8b | HK$103.6b | HK$3.6b | 37.7x | 44x | 1.5x |
| Fri, 15 Nov 2024 | HK$170.6b | HK$104.4b | HK$3.6b | 40.1x | 47.2x | 1.6x |
| Sun, 13 Oct 2024 | HK$181.8b | HK$105.4b | HK$3.3b | 52.2x | 54.4x | 1.7x |
| Tue, 10 Sep 2024 | HK$138.3b | HK$105.0b | HK$3.3b | 37.1x | 41.5x | 1.3x |
| Thu, 08 Aug 2024 | HK$139.7b | HK$103.1b | HK$2.4b | 42x | 57.9x | 1.4x |
| Sat, 06 Jul 2024 | HK$137.7b | HK$101.9b | HK$2.4b | 41.8x | 57.7x | 1.4x |
| Mon, 03 Jun 2024 | HK$155.3b | HK$102.4b | HK$2.4b | 45.7x | 64.8x | 1.5x |
| Wed, 01 May 2024 | HK$152.9b | HK$103.7b | HK$2.3b | 45.7x | 65.7x | 1.5x |
| Fri, 29 Mar 2024 | HK$158.8b | HK$103.6b | HK$13.7m | 48x | 11570.9x | 1.5x |
| Sun, 25 Feb 2024 | HK$175.9b | HK$105.1b | -HK$1,456,103,459.27 | 58.2x | -120.8x | 1.7x |
| Tue, 23 Jan 2024 | HK$154.5b | HK$105.0b | -HK$1,455,179,765.00 | 49.9x | -106.2x | 1.5x |
| Thu, 21 Dec 2023 | HK$201.3b | HK$105.7b | -HK$1,464,286,842.00 | 62.6x | -137.4x | 1.9x |
| Sat, 18 Nov 2023 | HK$211.7b | HK$102.9b | -HK$1,754,798,457.00 | 86.2x | -120.6x | 2.1x |
| Mon, 16 Oct 2023 | HK$224.7b | HK$102.4b | -HK$1,675,089,400.00 | 104.7x | -134.2x | 2.2x |
| Wed, 13 Sep 2023 | HK$233.4b | HK$102.6b | -HK$1,679,619,096.00 | 84.4x | -139x | 2.3x |
| Fri, 11 Aug 2023 | HK$280.3b | HK$95.9b | -HK$4,161,689,179.00 | 131.4x | -67.3x | 2.9x |
| Sun, 09 Jul 2023 | HK$255.0b | HK$95.8b | -HK$4,157,683,426.00 | 109.3x | -61.3x | 2.7x |
| Tue, 06 Jun 2023 | HK$271.5b | HK$97.0b | -HK$4,291,862,143.00 | 242.5x | -63.3x | 2.8x |
| Thu, 04 May 2023 | HK$298.3b | HK$95.5b | -HK$4,889,171,888.00 | 448x | -61x | 3.1x |
| Sat, 01 Apr 2023 | HK$317.6b | HK$96.0b | -HK$4,914,234,350.00 | 478.9x | -64.6x | 3.3x |
Price to Earnings Ratio
-116.3x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 64.1x which is lower than its 3-year average PE of 107x.
- The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.2x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 9.0% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 3.24% | |
| Consumer Staples | 2.26% | |
| Food and Staples Retail | 13.03% | |
| Drug Retail | 16.56% | |
| Big Box Super Stores | 6.33% | |
| Food Retail | -3.74% | |
| Food Distributors | -3.95% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1833 Ping An Healthcare and Technology | HK$9.31 | 26.5% +HK$4.2b | -26.5% | PS4.1x | |
| 6618 JD Health International | HK$36.75 | 3.4% +HK$3.8b | 19.9% | PE41.9x | |
| 241 Alibaba Health Information Technology | HK$6.04 | 2.4% +HK$2.3b | 70.6% | PE75.2x | |
| 6086 Fangzhou | HK$4.12 | 14.4% +HK$696.9m | n/a | PS2.1x | |
| 314 Sipai Health Technology | HK$5.29 | 5.4% +HK$205.3m | -19.8% | PS0.8x |